ArticleRSC advances2020
Smart magnetic nanopowder based on the manganite perovskite for local hyperthermia.
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- High-performance Fe-Al@BTC MOF for supercapacitor and antibacterial applications: experimental, DFT, and molecular docking studies.Scientific reports · 2026Article
- Molybdenum-doped LaRSC advances · 2025Article
- Titano-magnetite nanoparticles for supercapacitors and magnetic hyperthermia performance.Scientific reports · 2025Article
- Unlocking the Potential of Mg-Doped Rare Earth Manganites: Machine Learning-Guided Synthesis and Insights into Structural and Optical Properties.Nanomaterials (Basel, Switzerland) · 2025Article
- Structural, morphological, magnetic and electrical properties of LaRSC advances · 2024Article
- The Multifunctionality of Lanthanum-Strontium Cobaltite Nanopowder: High-Pressure Magnetic Studies and Excellent Electrocatalytic Properties for OER.ACS applied materials & interfaces · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For many medical applications related to diagnosis and treatment of cancer disease, hyperthermia plays an increasingly important role as a local heating method, where precise control of temperature and parameters of the working material is strongly required. Obtaining a smart material with "self-controlled" heating in a desirable temperature range is a relevant task. For this purpose, the nanopowder of manganite perovskite with super-stoichiometric manganese has been synthesized, which consists of soft spherical-like ferromagnetic nanoparticles with an average size of 65 nm and with a narrow temperature range of the magnetic phase transition at 42 °C. Based on the analysis of experimental magnetic data, a specific loss power has been calculated for both quasi-stable and relaxation hysteresis regions. It has been shown that the local heating of the cell structures to 42 °C may occur for a short time (∼1.5 min.) Upon reaching 42 °C, the heating is stopped due to transition of the nanopowder to the paramagnetic state. The obtained results demonstrate the possibility of using synthesized nanopowder as a smart magnetic nanomaterial for local hyperthermia with automatic heating stabilization in the safe range of hyperthermia without the risk of mechanical damage to cell structures.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.